Whole body functional MR imaging: Hemato-oncologic applications;IRM fonctionnelle corps entier : Applications hématologiques

Journal de Radiologie

Volumn 91, Issue 3 C2, 2010, Pages 375-380

  Luciani, A ^a   Lin, C ^a   Beaussart, P ^a   Zerbib, P ^a   Haioun, C ^a   Rahmouni, A ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Contrast agent; Diffusion; Functional MRI; Lymphoma; MRI; Myeloma

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CANCER STAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; IMAGING SYSTEM; LYMPHOMA; MULTIPLE MYELOMA; WHOLE BODY MRI;

EID: 77951050740     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(10)70053-6     Document Type: Article

References (46)

1. Lin C, Luciani A, Itti E, Haioun C, Rahmouni A. Whole body MRI and PET/CT in haematological malignancies. Cancer Imaging 2007;7 Spec No A: S88-93.
2. Durie BG. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 2006;42:1539-1543
3. Rahmouni A, Luciani A, Itti E. MRI and PET in monitoring response in lymphoma. Cancer Imaging 2005;5 Spec No A : S106-12.
4. Durie BG, Harousseau JL, Miguel JS et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-1473
5. Greipp PR, San Miguel J, Durie BG et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-3420
6. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 2009;70:393-400.
7. Rahmouni A, Luciani A, Itti E. Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria). Cancer Imaging 2005;5 Spec No A: S102-6.
8. Lin C, Itti E, Haioun C et al. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUVbased assessment versus visual analysis. J Nucl Med 2007;48:1626-1632
9. Itti E, Lin C, Dupuis J et al. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy. J Nucl Med 2009;50:527-533
10. Haioun C, Itti E, Rahmouni A et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005;106: 1376-1381
11. Haioun C, Itti E, Rahmouni A, Meignan M, Reyes F. PET scan in the therapeutic strategy. Hematol J 2004;5 Suppl 3: S149-53.
12. Lauenstein TC, Semelka RC. Whole-body magnetic resonance imaging. Top Magn Reson Imaging 2005;16:15-20.
13. Lauenstein TC, Freudenberg LS, Goehde SC et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002;12:2091-2099
14. Schmidt GP, Kramer H, Reiser MF, Glaser C. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Top Magn Reson Imaging 2007;18: 193-202.
15. Lauenstein TC, Semelka RC. Emerging techniques: whole-body screening and staging with MRI. J Magn Reson Imaging 2006;24;489-498
16. Li S, Sun F, Jin ZY, Xue HD, Li ML. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging 2007;26:1139-1144
17. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004;22:275-282
18. Kumar S, Gertz MA, Dispenzieri A et al. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 2004;34:235-239
19. Rajkumar SV, Leong T, Roche PC et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000;6:3111-3116
20. Bhatti SS, Kumar L, Dinda AK, Dawar R. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters. Am J Hematol 2006;81: 649-656
21. Nosàs-Garcia S, Moehler T, Wasser K et al. Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers. J Magn Reson Imaging 2005;22: 154-162
22. Rahmouni A, Montazel JL, Divine M et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology 2003;229:710-717
23. Rahmouni A, Divine M, Mathieu D et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;160:1049-1052
24. Rahmouni A, Divine M, Mathieu D et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 1993;160:1053-1057
25. Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings. Cancer 2004;101: 2599-2604
26. Schmidt GP, Baur-Melnyk A, Herzog P et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography- computed tomography: experience on a 32-channel system. Invest Radiol 2005;40:743-753
27. Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A. Wholebody MR imaging of bone marrow. Eur J Radiol 2005;55:33-40.
28. Lin C, Luciani A, Belhadj K et al. Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience. Radiology 2009;250:905-915
29. Lauenstein TC, Goehde SC, Herborn CU et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol 2002;179:445-449
30. Rofsky NM, Lee VS, Laub G et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884
31. Lin C, Luciani A, Belhadj K et al. Multiple myeloma treatment response assessment by whole-body dynamic contrast-enhanced MR imaging. Radiology 2010;254:521-531
32. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992;159:591-599
33. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval- Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
34. Stejskal EO, Tanner JE. Spin Diffusion Measurement : Spin Echoes in the Presence of a Time-dependant Field Gradient. The Journal of Chemical Physics 1965. 42;288
35. Skare S, Newbould RD, Clayton DB, Albers GW, Nagle S, Bammer R. Clinical multishot DW-EPI through parallel imaging with considerations of susceptibility, motion, and noise. Magn Reson Med 2007;57:881-890
36. Oner AY, Tali T, Celikyay F, Celik A, Le Roux P. Diffusionweighted imaging of the spine with a non-carr-purcell-meiboomgill single-shot fast spin-echo sequence: initial experience. AJNR Am J Neuroradiol 2007;28: 575-580
37. Coenegrachts K, Delanote J, Ter Beek L et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007;80:524-531
38. De Foer B, Vercruysse JP, Pilet B et al. Single-shot, turbo spinecho, diffusion-weighted imaging versus spin-echo-planar, diffusion- weighted imaging in the detection of acquired middle ear cholesteatoma. AJNR Am J Neuroradiol 2006;27: 1480-1482
39. Liu G, Ogawa S. EPI image reconstruction with correction of distortion and signal losses. J Magn Reson Imaging 2006;24:683-689
40. Padhani AR, Liu G, Koh DM et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102-125
41. Le Bihan D, Turner R, MacFall JR. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989;10: 324-337
42. Luciani A, Vignaud A, Cavet M et al. Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology 2008;249: 891-899
43. Bruegel M, Holzapfel K, Gaa J et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion- weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18:477-485
44. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008;248:894-900.
45. Vilanova JC, Barcelo J. Diffusion-weighted whole-body MR screening. Eur J Radiol 2008;67:440-447
46. Li S, Xue HD, Li J et al. Application of whole body diffusion weighted MR imaging for diagnosis and staging of malignant lymphoma. Chin Med Sci J 2008;23:138-144